Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Havrix 3-dose vs 2-dose in advanced fibrosis and cirrhosis
NCT06277882Phase 4Recruiting
- Sponsor
- Mahidol University
- Start
- Feb 2024
- Primary completion
- Mar 2025
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of Hepatitis A virus vaccine in hepatitis A (HAV), sponsored by Mahidol University. Started Feb 2024; status: recruiting.
02
Drugs
Hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT06277882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06277882.